# Chain Bridge Bancorp Inc: financial statements, quarterly

CBNA · NYSE · CIK 1392272 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cbna.md) · [Financials](/companies/cbna/financials.md) · [Filings](/companies/cbna/filings.md) · [Insiders](/companies/cbna/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cbna/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Income tax | $k | [676](/filings/0001392272-24-000020.md) | [838 d](/filings/0001392272-25-000019.md) | [976](/filings/0001392272-25-000028.md) | [1,492](/filings/0001392272-25-000041.md) | [1,925](/filings/0001628280-25-050658.md) | [926 d](/filings/0001628280-26-020177.md) | [1,430](/filings/0001628280-26-034040.md) | [1,193](/filings/0001628280-26-055560.md) | [1,193](/filings/0001628280-25-050658.md) | [1,362 d](/filings/0001628280-26-020177.md) | [1,826](/filings/0001628280-26-034040.md) | [2,477](/filings/0001628280-26-055560.md) |
| Net income | $k | [2,843](/filings/0001392272-24-000020.md) | [3,314 d](/filings/0001392272-25-000019.md) | [3,917](/filings/0001628280-25-050658.md) | [5,805](/filings/0001628280-25-050658.md) | [7,487](/filings/0001628280-25-050658.md) | [3,740 d](/filings/0001628280-26-020177.md) | [5,607](/filings/0001628280-26-055560.md) | [4,584](/filings/0001628280-26-055560.md) | [4,702](/filings/0001628280-25-050658.md) | [5,344 d](/filings/0001628280-26-020177.md) | [7,072](/filings/0001628280-26-055560.md) | [9,512](/filings/0001628280-26-055560.md) |
| Diluted EPS | $ per share | [0.62](/filings/0001392272-24-000020.md) | not reported | [0.86](/filings/0001392272-25-000028.md) | [1.27](/filings/0001392272-25-000041.md) | [1.64](/filings/0001628280-25-050658.md) | not reported | [0.85](/filings/0001628280-26-034040.md) | [0.70](/filings/0001628280-26-055560.md) | [0.72](/filings/0001628280-25-050658.md) | not reported | [1.08](/filings/0001628280-26-034040.md) | [1.45](/filings/0001628280-26-055560.md) |
| Basic EPS | $ per share | [0.62](/filings/0001392272-24-000020.md) | not reported | [0.86](/filings/0001392272-25-000028.md) | [1.27](/filings/0001392272-25-000041.md) | [1.64](/filings/0001628280-25-050658.md) | not reported | [0.85](/filings/0001628280-26-034040.md) | [0.70](/filings/0001628280-26-055560.md) | [0.72](/filings/0001628280-25-050658.md) | not reported | [1.08](/filings/0001628280-26-034040.md) | [1.45](/filings/0001628280-26-055560.md) |

- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [317](/filings/0001392272-25-000019.md) | not reported | not reported | [640](/filings/0001392272-24-000020.md) | [411](/filings/0001628280-26-020177.md) | [629](/filings/0001392272-25-000028.md) | [377](/filings/0001392272-25-000041.md) | [396](/filings/0001628280-25-050658.md) | [587](/filings/0001628280-26-055560.md) | [612](/filings/0001628280-26-034040.md) | [822](/filings/0001628280-26-055560.md) |
| Total assets | $m | not reported | [1,205](/filings/0001392272-25-000019.md) | not reported | not reported | [1,555](/filings/0001392272-24-000020.md) | [1,401](/filings/0001628280-26-020177.md) | [1,727](/filings/0001392272-25-000028.md) | [1,445](/filings/0001392272-25-000041.md) | [1,534](/filings/0001628280-25-050658.md) | [1,750](/filings/0001628280-26-055560.md) | [1,919](/filings/0001628280-26-034040.md) | [2,193](/filings/0001628280-26-055560.md) |
| Total liabilities | $m | not reported | [1,122](/filings/0001392272-25-000019.md) | not reported | not reported | [1,450](/filings/0001392272-24-000020.md) | [1,257](/filings/0001628280-26-020177.md) | [1,575](/filings/0001392272-25-000028.md) | [1,288](/filings/0001392272-25-000041.md) | [1,371](/filings/0001628280-25-050658.md) | [1,581](/filings/0001628280-26-055560.md) | [1,744](/filings/0001628280-26-034040.md) | [2,009](/filings/0001628280-26-055560.md) |
| Short-term borrowings | $m | not reported | [5.0](/filings/0001392272-25-000019.md) | not reported | not reported | [10.0](/filings/0001392272-24-000020.md) | [0.0](/filings/0001628280-26-020177.md) | [0.0](/filings/0001392272-25-000028.md) | [0.0](/filings/0001392272-25-000041.md) | [0.0](/filings/0001628280-25-050658.md) | [0.0](/filings/0001628280-26-055560.md) | [0.0](/filings/0001628280-26-034040.md) | [0.0](/filings/0001628280-26-055560.md) |
| Shareholders' equity | $m | [75.2](/filings/0001392272-24-000020.md) | [83.4](/filings/0001628280-26-020177.md) | [87.6](/filings/0001628280-25-050658.md) | [94.0](/filings/0001628280-25-050658.md) | [105](/filings/0001628280-25-050658.md) | [144](/filings/0001628280-26-055560.md) | [152](/filings/0001628280-26-055560.md) | [157](/filings/0001628280-26-055560.md) | [163](/filings/0001628280-25-050658.md) | [169](/filings/0001628280-26-055560.md) | [175](/filings/0001628280-26-055560.md) | [184](/filings/0001628280-26-055560.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [5,508 d](/filings/0001392272-25-000019.md) | [3,471](/filings/0001392272-25-000028.md) | [5,802 d](/filings/0001392272-25-000041.md) | [8,244 d](/filings/0001628280-25-050658.md) | [4,280 d](/filings/0001628280-26-020177.md) | [3,109](/filings/0001628280-26-034040.md) | [3,350 d](/filings/0001628280-26-055560.md) | [2,780 d](/filings/0001628280-25-050658.md) | [6,355 d](/filings/0001628280-26-020177.md) | [3,642](/filings/0001628280-26-034040.md) | [8,972 d](/filings/0001628280-26-055560.md) |
| Capital expenditure | $k | [221 d](/filings/0001392272-25-000019.md) | [60.0](/filings/0001392272-25-000028.md) | [39.0 d](/filings/0001392272-25-000041.md) | [28.0 d](/filings/0001628280-25-050658.md) | [96.0 d](/filings/0001628280-26-020177.md) | [1,689](/filings/0001628280-26-034040.md) | [820 d](/filings/0001628280-26-055560.md) | [322 d](/filings/0001628280-25-050658.md) | [1,281 d](/filings/0001628280-26-020177.md) | [752](/filings/0001628280-26-034040.md) | [2,710 d](/filings/0001628280-26-055560.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2023-09-30) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [4,568](/filings/0001392272-24-000020.md) | [4,568](/filings/0001392272-25-000028.md) | [4,569](/filings/0001392272-25-000041.md) | [4,569](/filings/0001628280-25-050658.md) | [6,562](/filings/0001628280-26-034040.md) | [6,562](/filings/0001628280-26-055560.md) | [6,562](/filings/0001628280-25-050658.md) | [6,562](/filings/0001628280-26-034040.md) | [6,562](/filings/0001628280-26-055560.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.